This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Research » Treatments

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

TZD’s Connected to Vision-Threatening Complication

Posted: Wednesday, April 15, 2009

Treatment with the glitazone class of diabetes drugs leads to a "modest" increase in the risk of diabetic macular edema (DME)—a common complication that can lead to vision loss, reports a study.

Liraglutide Has Low CVD Risk but May Be Blocked for Approval

Posted: Wednesday, April 15, 2009

Tumor data may block approval for diabetes drug liraglutide. An FDA advisory panel declined to recommend approval for the investigational diabetes drug liraglutide (Victoza), in light of animal studies linking the injection to thyroid cancer.

The Next DPP-4 Inhibitor Onglyza™ Passes CVD Review: Coming Soon

Posted: Wednesday, April 15, 2009

An FDA panel voted 10-2 that the investigational diabetes drug saxagliptin (Onglyza) does not put Type 2 diabetes patients at an increased risk for cardiovascular events, but wants drugmaker Bristol-Myers Squibb to conduct long-term postmarketing studies to test the drug in older and sicker patients.

Olive Oil Compound Protects Against Heart Disease

Posted: Saturday, April 11, 2009

Already known to have general antioxidant properties, a specific antioxidant compound within olive oil has recently been identified, that may explain why people whose diets are high in olive oil have a lower incidence of cardiovascular disease (CVD).

New Link Between Obesity and Insulin Resistance Uncovered

Posted: Saturday, April 11, 2009

The high BCAA protein levels found in obese individuals, combined with high fat diets, could significantly increase the incidence of pre-diabetic insulin resistance. Because obesity and diabetes are so closely linked, this finding could go a long way in explaining the cause and effect of the obesity-diabetes connection, as well as lay the foundations for future preventative treatments for diabetes in obese individuals.

Brown Fat Could Help Treat Obesity and Diabetes

Posted: Friday, April 10, 2009

Brown fat, which helps use energy and burn calories, and was previously believed to only to exist in babies, has recently been shown to occur in adults as well. The discovery of the presence of this "good fat" in adults lays foundations for potential obesity and diabetes treatments that stimulate brown fat growth.

Bariatric Surgery Causes Most Cases of Type 2 to Remit Long-Term

Posted: Thursday, March 26, 2009

In morbidly obese patients with Type 2 diabetes, bariatric surgery leads to resolution or improvement of the disease in close to 90% of cases, with benefits usually maintained for at least 2 years, according to a meta-analysis.

FDA Announces New Recommendations on Evaluating Cardiovascular Risk in Drugs Intended to Treat Type 2 Diabetes

Posted: Thursday, March 26, 2009

The FDA recommended that manufacturers developing new drugs and biologics for Type 2 diabetes provide evidence that the therapy will not increase the risk of such cardiovascular events as a heart attack. The recommendation is part of a new guidance for industry that applies to all diabetes drugs currently under development.

Barley Reduces LDL Cholesterol and Triglycerides

Posted: Thursday, March 26, 2009

Barley may play a role in reducing cardiovascular risk, a meta-analysis showed. Patients who ate barley regularly had a statistically significant reduction in total cholesterol, LDL cholesterol, and triglycerides.

South Asians More at Risk for Diabetic Retinopathy

Posted: Tuesday, March 24, 2009

A recent study out of England has concluded that South Asians are significantly more likely to suffer from diabetic retinopathy than Caucasian Europeans. This is troubling news, especially for the densely populated, and highly diabetic, country of India.